Your browser doesn't support javascript.
loading
Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review.
Bradbury, Michelle; Hutton, Brian; Beltran-Bless, Ana-Alicia; Alzahrani, Mashari; Lariviere, Thomas; Fernandes, Ricardo; Ibrahim, Mohammed Fk; Cole, Katherine; Hilton, John; Vandermeer, Lisa; Shorr, Risa; Larocque, Gail; Clemons, Mark.
Afiliación
  • Bradbury M; Department of Medicine, The Ottawa Hospital, Ottawa, Canada.
  • Hutton B; Clinical Epidemiology Program, Ottawa Hospital Research Institute and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
  • Beltran-Bless AA; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada.
  • Alzahrani M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada.
  • Lariviere T; Department of Family Medicine, The Ottawa Hospital, Ottawa, Canada.
  • Fernandes R; Division of Medical Oncology, Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
  • Ibrahim MF; Thunder Bay Regional Health Sciences Centre-Cancer Care, Thunder Bay, Canada.
  • Cole K; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada.
  • Hilton J; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Vandermeer L; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Shorr R; The Ottawa Hospital, Ottawa, Canada.
  • Larocque G; The Ottawa Hospital, Ottawa, Canada.
  • Clemons M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada. Electronic address: mclemons@toh.ca.
Clin Breast Cancer ; 22(3): e362-e373, 2022 04.
Article en En | MEDLINE | ID: mdl-34740542
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos